VeriMom¿Es zinc palmitoyl nonapeptide-14 seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
Pregnancy-safe products containing zinc palmitoyl nonapeptide-14
Related ingredients
Frequently asked questions
- ¿Es zinc palmitoyl nonapeptide-14 seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction identified for zinc palmitoyl nonapeptide-14. No peer-reviewed or regulatory evidence of developmental or reproductive toxicity for this cosmetic peptide was found in the referenced sources; peptides of this size are generally of low dermal systemic absorption, supporting negligible exposure with normal topical cosmetic use (ECHA Annex VI: no harmonised classification; CosIng / PubChem: no repro hazard listed).
- ¿Es zinc palmitoyl nonapeptide-14 seguro durante la lactancia?
- No evidence of reproductive or lactation-specific hazards from SCCS/CIR/ECHA or peer-reviewed literature for this ingredient. Dermal absorption is expected to be negligible for a large, palmitoylated peptide; therefore systemic exposure sufficient to reach breastmilk is not supported by available regulatory sources (no ECHA harmonised hazard, no CIR or SCCS contraindication).
- ¿Es zinc palmitoyl nonapeptide-14 seguro para la piel del bebé?
- No data indicating intrinsic developmental or reproductive hazard in infants. Mechanistic data are absent. Although adult dermal absorption is expected to be negligible, infant skin has higher surface-area-to-weight and an immature barrier; per the scoring guidance, exposure score is increased by +1 relative to adult (from 0 to 1) in the absence of evidence of complete non-absorbability. No infant-specific adverse data were found in the searched regulatory sources.
- ¿Cómo puntúa VeriMom a zinc palmitoyl nonapeptide-14?
- VeriMom puntúa zinc palmitoyl nonapeptide-14 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a zinc palmitoyl nonapeptide-14 en el embarazo?
- Consulta nuestra lista de alternativas seguras a zinc palmitoyl nonapeptide-14 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.